66203-02-9 Usage
Chemical structure
A complex chemical compound with a benzofuran ring and a urea group, containing a 2-azocan-1-ylethoxy side chain and a methyl group attached to the urea moiety.
Benzofuran ring
A heterocyclic aromatic ring consisting of a benzene ring fused to a furan ring.
2-azocan-1-ylethoxy side chain
A side chain attached to the benzofuran ring, consisting of an azocane ring connected to an ethoxy group.
Methoxy substitution
The benzofuran ring is substituted with two methoxy groups at positions 4 and 7.
Methyl group
A small alkyl group (-CH3) attached to the urea moiety.
Potential applications
The compound may have potential uses in pharmaceuticals, agrochemicals, or material science.
Further research
Additional studies would be required to determine the specific uses and properties of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 66203-02-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,2,0 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 66203-02:
(7*6)+(6*6)+(5*2)+(4*0)+(3*3)+(2*0)+(1*2)=99
99 % 10 = 9
So 66203-02-9 is a valid CAS Registry Number.
66203-02-9Relevant academic research and scientific papers
Synthesis and Antiarrhythmic Activity of New Benzofuran Derivatives
Bourgery, Guy,Dostert, Philippe,Lacour, Alain,Langlois, Michel,Pourrias, Bernard,Tisne-Versailles, Jacky
, p. 159 - 167 (2007/10/02)
Various 5-aminobenzofuran derivatives were prepared from khellin and screened intravenously in the dog for their potential antiarrhythmic activity against ouabain-induced ventricular arrhythmia and in the Harris test.From systematic structural variations it was found that two methoxy groups in positions 4 and 7 on the benzofuran ring, a tertiary aminoethoxy side chain in position 6, and a N-methylurea group in position 5 led to the most active compounds.These were then tested orally in the Harris test in the dog.The two long-acting derivativesN--N'-methylurea (8j) and N--N'-methylurea (8m) showed advantages when compared to quinidine and diisopyramide and have been selected for further studies.
